| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ACADIA Pharmaceuticals Inc (NASDAQ: ACAD)
ACAD Technical Analysis
5
| As on 12th Dec 2025 ACAD STOCK Price closed @ 27.15 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 20.06 & Strong Buy for SHORT-TERM with Stoploss of 18.01 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ACADSTOCK Price
| Open | 26.75 | Change | Price | % |
| High | 27.28 | 1 Day | 0.47 | 1.76 |
| Low | 26.42 | 1 Week | 1.27 | 4.91 |
| Close | 27.15 | 1 Month | 4.41 | 19.39 |
| Volume | 1266078 | 1 Year | 10.83 | 66.36 |
| 52 Week High 27.44 | 52 Week Low 14.10 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| OCG | 0.22 | -75.82% |
| NVDA | 175.02 | -3.27% |
| CGC | 1.74 | 53.98% |
| LMDX | 0.02 | 0.00% |
| PLUG | 2.32 | -1.69% |
| YGMZ | 0.02 | -66.67% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ACAD Daily Charts |
ACAD Intraday Charts |
Whats New @ Bazaartrend |
ACAD Free Analysis |
|
|
ACAD Important Levels Intraday
| RESISTANCE | 28.81 |
| RESISTANCE | 28.28 |
| RESISTANCE | 27.95 |
| RESISTANCE | 27.62 |
| SUPPORT | 26.68 |
| SUPPORT | 26.35 |
| SUPPORT | 26.02 |
| SUPPORT | 25.49 |
ACAD Forecast December 2025
| 4th UP Forecast | 33.16 |
| 3rd UP Forecast | 31.23 |
| 2nd UP Forecast | 30.04 |
| 1st UP Forecast | 28.85 |
| 1st DOWN Forecast | 25.45 |
| 2nd DOWN Forecast | 24.26 |
| 3rd DOWN Forecast | 23.07 |
| 4th DOWN Forecast | 21.14 |
ACAD Weekly Forecast
| 4th UP Forecast | 31.52 |
| 3rd UP Forecast | 30.12 |
| 2nd UP Forecast | 29.25 |
| 1st UP Forecast | 28.39 |
| 1st DOWN Forecast | 25.91 |
| 2nd DOWN Forecast | 25.05 |
| 3rd DOWN Forecast | 24.18 |
| 4th DOWN Forecast | 22.78 |
ACAD Forecast2025
| 4th UP Forecast | 54.76 |
| 3rd UP Forecast | 45.91 |
| 2nd UP Forecast | 40.43 |
| 1st UP Forecast | 34.96 |
| 1st DOWN Forecast | 19.34 |
| 2nd DOWN Forecast | 13.87 |
| 3rd DOWN Forecast | 8.39 |
| 4th DOWN Forecast | -0.46 |
ACADIA Pharmaceuticals Inc ( NASDAQ USA Symbol : ACAD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ACAD Business Profile
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; Trofinetide, a novel synthetic analog for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor for treating cognition and schizophrenia. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California. Address: 12830 El Camino Real, San Diego, CA, United States, 92130
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service